These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27906878)

  • 1. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer.
    Łukaszewicz-Zając M; Kulczyńska-Przybik A; Muszyński P; Kozłowski M; Szmitkowski M; Mroczko B
    Pol Arch Med Wewn; 2016 Oct; 126(11):854-861. PubMed ID: 27906878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Kędra B; Mroczko B
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
    Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.
    Pączek S; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Anticancer Res; 2021 Mar; 41(3):1421-1428. PubMed ID: 33788733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
    Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
    J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
    Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
    Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients.
    Łukaszewicz-Zając M; Pączek S; Muszyński P; Kozłowski M; Mroczko B
    Clin Exp Med; 2019 May; 19(2):191-199. PubMed ID: 30820705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
    Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
    Groblewska M; Mroczko B; Kozlowski M; Niklinski J; Laudanski J; Szmitkowski M
    Folia Histochem Cytobiol; 2012; 50(4):590-8. PubMed ID: 23264224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
    J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Pol Arch Med Wewn; 2009 Sep; 119(9):558-63. PubMed ID: 19776700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 and C-reactive protein in esophageal cancer.
    Groblewska M; Mroczko B; Sosnowska D; Szmitkowski M
    Clin Chim Acta; 2012 Oct; 413(19-20):1583-90. PubMed ID: 22609487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative elevation of serum C-reactive protein as an indicator of poor prognosis for early-stage esophageal squamous cell carcinoma.
    Song ZB; Lin BC; Li B; He CX; Zhang BB; Shao L; Zhang YP
    Kaohsiung J Med Sci; 2013 Dec; 29(12):662-6. PubMed ID: 24296054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms.
    Micheli DC; Jammal MP; Martins-Filho A; Côrtes JRXM; Souza CN; Nomelini RS; Murta EFC; Tavares-Murta BM
    Biomarkers; 2020 Sep; 25(6):474-482. PubMed ID: 32544350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Wereszczyńska-Siemiatkowska U; Kedra B; Lukaszewicz M; Baniukiewicz A; Szmitkowski M
    Clin Chem Lab Med; 2008; 46(10):1423-8. PubMed ID: 18844497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.